Related Experiment Video

Updated: Jun 2, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

mTOR kinase domain phosphorylation promotes mTORC1 signaling, cell growth, and cell cycle progression

Bilgen Ekim1, Brian Magnuson, Hugo A Acosta-Jaquez

  • 1Department of Cell and Developmental Biology, Division of Metabolism, Endocrinology, and Diabetes, 109 Zina Pitcher Place, University of Michigan Medical School, Ann Arbor, MI 48109-2200, USA.

Molecular and Cellular Biology
|May 18, 2011
PubMed

Insights

New research reveals how mTORC1 senses signals through specific mTOR phosphorylation sites (S2159/T2164). This dual phosphorylation enhances mTORC1 signaling, promoting cell growth and proliferation by modulating protein interactions and kinase activity.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • The mammalian target of rapamycin complex 1 (mTORC1) is a crucial regulator of cellular processes, responding to environmental cues like nutrients and growth factors.
  • The precise molecular mechanisms by which mTORC1 senses and transduces these signals are not fully understood.
  • Investigating mTOR phosphorylation offers a potential avenue to elucidate mTORC1 signaling pathways.

Purpose of the Study:

  • To investigate the role of specific phosphorylation sites within the mTOR kinase domain in regulating mTORC1 function.
  • To identify novel phosphorylation sites on mTOR and determine their impact on mTORC1 signaling.
  • To elucidate the mechanistic link between mTOR phosphorylation and the promotion of cellular growth and proliferation.

Main Methods:

  • Mass spectrometry was utilized to identify novel phosphorylation sites on mTOR.
  • Phospho-specific antibodies were generated and employed to detect mTOR phosphorylation at S2159 and T2164.
  • Site-directed mutagenesis was performed to analyze the functional consequences of S2159 and T2164 phosphorylation.
  • Interactions between mTOR, raptor, and PRAS40 were assessed.
  • mTORC1 kinase activity and downstream signaling to S6K1 and 4EBP1 were measured.

Main Results:

  • Novel phosphorylation sites at S2159 and T2164 within the mTOR kinase domain were identified.
  • Dual phosphorylation at S2159/T2164 was found to cooperatively enhance mTORC1 signaling towards S6K1 and 4EBP1.
  • Mechanistically, S2159/T2164 phosphorylation altered mTOR-raptor and raptor-PRAS40 interactions and increased mTOR S2481 autophosphorylation.
  • mTOR S2159/T2164 phosphorylation was shown to promote cell growth and cell cycle progression.

Conclusions:

  • mTOR kinase domain phosphorylation, specifically at S2159 and T2164, plays a critical role in modulating mTORC1 activity.
  • This phosphorylation event enhances mTORC1 signaling by altering protein-protein interactions and augmenting kinase activity.
  • The findings provide a mechanistic model for how mTORC1 senses signals and promotes essential cellular processes like growth and proliferation.

More Related Videos

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...